KORU Medical Systems, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 10, 2026 (14 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Mar 13, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Mar 13, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 54% |
| Dec 22, 2025 | Lake Street | maintain | Buy → Buy | $8 | 47% |
| Dec 17, 2025 | Canaccord Genuity | maintain | Buy → Buy | $6 | 48% |
| Aug 7, 2025 | Piper Sandler | maintain | Neutral → Neutral | $4 | 54% |
| May 8, 2025 | Piper Sandler | maintain | Neutral → Neutral | $3.5 | 54% |
| Feb 14, 2025 | Piper Sandler | downgrade | Overweight → Neutral | $4.5 | 54% |
| Jan 17, 2025 | Craig-Hallum | maintain | Buy → Buy | $6 | 54% |
| Jan 14, 2025 | Lake Street | maintain | Buy → Buy | $5 | 47% |
| Nov 14, 2024 | Craig-Hallum | maintain | Buy → Buy | $5 | 54% |
| Nov 14, 2024 | Canaccord Genuity | maintain | Buy → Buy | $4 | 48% |
| Nov 14, 2024 | Piper Sandler | maintain | Overweight → Overweight | $3.5 | 54% |
| Aug 8, 2024 | Piper Sandler | maintain | Overweight → Overweight | $3 | 54% |
| Mar 14, 2024 | B. Riley Securities | reiterate | Buy → Buy | $4 | 54% |
| Dec 7, 2023 | Canaccord Genuity | reiterate | Buy → Buy | $3 | 48% |
| Sep 7, 2023 | Lake Street | initiate | — → Buy | $4 | 47% |
| Sep 7, 2023 | B. Riley Securities | initiate | — → Buy | $4.5 | 54% |
| Aug 3, 2023 | Piper Sandler | maintain | Overweight → Overweight | $3 | 54% |
| Jan 6, 2023 | Piper Sandler | maintain | — → Overweight | $4.5 | 54% |
| Nov 10, 2022 | Canaccord Genuity | upgrade | Hold → Buy | $4 | 48% |
| Nov 10, 2022 | Piper Sandler | upgrade | Neutral → Overweight | $3.5 | 54% |
| Jan 26, 2021 | Canaccord Genuity | downgrade | Buy → Hold | $5 | 48% |
| Jan 26, 2021 | Piper Sandler | downgrade | Overweight → Neutral | $4.5 | 54% |
| Nov 5, 2020 | Canaccord Genuity | maintain | — → Buy | $10 | 48% |
| Jul 16, 2020 | Canaccord Genuity | initiate | — → Buy | $13 | 48% |
| Jun 24, 2020 | Piper Sandler | initiate | — → Overweight | $12 | 54% |
No cross-platform signals in the last 90 days